xx醫(yī)院抗腫瘤藥物臨床用藥分析

摘要：目的 調(diào)查xx醫(yī)院腫瘤科2011—2012年度住院患者的針劑抗腫瘤藥物的使用情況，對(duì)xx醫(yī)院針劑抗腫瘤藥物的使用現(xiàn)狀進(jìn)行分析，為今后該院更合理、有效、經(jīng)濟(jì)地使用抗腫瘤藥物提供參考依據(jù)。方法 對(duì)xx醫(yī)院腫瘤科2011—2012年度住院患者抗腫瘤針劑藥物的用藥種類(lèi)、數(shù)量及銷(xiāo)售金額進(jìn)行統(tǒng)計(jì)，采用銷(xiāo)售金額、用藥數(shù)量排序法，用藥頻度（DDDs）、日均費(fèi)用（DDDc）和限定日劑量（DDD）法，回顧性地分析xx醫(yī)院2011—2012年兩年間抗腫瘤針劑藥物的臨床用藥情況。結(jié)果 經(jīng)統(tǒng)計(jì)兩年間xx醫(yī)院腫瘤科抗腫瘤針劑藥物用藥量最大的為氟尿嘧啶，銷(xiāo)售金額排名第一的是紫杉醇，用藥頻度（DDDs）最大的為氟尿嘧啶。無(wú)論是用藥量還是銷(xiāo)售金額2012年較2011年都有很大的增長(zhǎng)。結(jié)論 腫瘤用藥情況呈上升趨勢(shì)，銷(xiāo)售金額增勢(shì)較猛，提示xx醫(yī)院在保證治療效果的情況下，盡可能選擇安全、有效、經(jīng)濟(jì)的用藥方案，以減輕患者的經(jīng)濟(jì)負(fù)擔(dān)。
關(guān)鍵詞：用藥頻度（DDDs）；銷(xiāo)售金額 ；抗腫瘤針劑藥物
Abstract: Objective investigation of hospitalized patients with 2011-2012 injection antitumor drug use situation, for the ninth hospital injection, analyzing the present situation and problems of the use of drugs to the institute for the future is more reasonable, effective and economical use of antineoplastic drugs provide a reference basis. Method to the ninth hospital oncology 2011-2012 annual inpatients antitumor drug injection drug type and quantity and sales amount of statistics, sales amount, number of sorting method is used, the frequency (DDDs) and average daily costs (DDDc) and limit daily dose (DDD) method, the ninth hospital were retrospectively analyzed in 2011-2012 two years injection drug clinical antitumor drugs. Rsult through two years hospital oncology antitumor largest for fluorouracil injection drug dose, ranked first in sales amount of taxol, drug use frequency to fluorouracil (DDDs) maximum. Both dose and the sales amount in 2012 than in 2011 has great growth. Conclusion tumor drug use situation is on the rise, the sales amount growth rapidly, prompt the ninth hospital in the case of guarantee treatment effect, as far as possible choose safe, effective and economic medication scheme, in order to reduce the economic burden of patients.
Keywords: frequency (DDDs); The sales amount; Antitumor drug injection